FDA record · 503B outsourcing facility

Atilar Pharma Corporation: FDA 503B outsourcing facility record

Atilar Pharma Corporation in Houston, TX is on FDA's register of 503B outsourcing facilities. Registered since Feb 20, 2025; not yet inspected by FDA. Register updated by FDA Sep 30, 2026.

Julian CaraulaniFounder, PriceTracker GLP-1FDA register read Oct 3

Status: Registered since Feb 20, 2025; not yet inspected by FDA.

What FDA’s register states

FDA register entry for Atilar Pharma Corporation
Field	What FDA’s record states	Source
Facility	Atilar Pharma Corporation	FDA register
Location	Houston, TX	FDA register
First registered	Feb 20, 2025	FDA register
Most recent registration	Dec 24, 2025	FDA register
Last FDA inspection	Not yet inspected	FDA register
Form 483 issued	Not published by FDA	FDA register
Recall conducted	Not published by FDA	FDA register
Action based on last inspection	Not published by FDA	FDA register
Earlier compounding action	Not published by FDA	n/a
Intends to compound sterile drugs from bulk	Yes	FDA register

Registration is a filing, not an approval.A Form FDA 483 lists what investigators observed; in FDA’s words it “does not constitute a final agency determination of whether any condition is in violation of the FD&C Act or any relevant regulations.” “Open” means FDA has not determined whether further action will be taken.

Source

Copied from FDA’s Registered Outsourcing Facilities table ↗, updated by FDA Sep 30, 2026, read Oct 3, 2026. The table does not include State Board of Pharmacy actions. All 98 registered facilities